IRVINE, Calif., May 17, 2012 (HSMN NewsFeed) -- Masimo (MASI) announced today a new study published in the May 2012 edition of the British Journal of Anaesthesia demonstrates that Masimo's acoustic respiration rate (RRa™) from rainbow® Acoustic Monit...
Devices, Monitoring, Surgery
Masimo, acoustic respiration rate, Acoustic Monitoring, respiratory depression

May 17, 2012 -- (Healthcare Sales & Marketing Network) -- Minimus Spine, Inc. (www.minimusspine.com) announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (Application 11/527,414), adding a third patent to its...
Devices, Orthopaedic, Neurosurgery
Minimus Spine, TrioJection, ozone, disc herniation

Amendment Accepted By FDA, Enhancing and Upgrading the Trial 41 US Clinical Trial Sites Now In Operation BETHESDA, Md., May 17, 2012 (HSMN NewsFeed) -- Northwest Biotherapeutics (NWBO.OB) (NW Bio) announced today that it now has 41 clinical trial s...
Biopharmaceuticals, Oncology, FDA
Northwest Biotherapeutics, DCVax, Glioblastoma

SUNNYVALE, Calif., May 17, 2012 (HSMN NewsFeed) -- Accuray Incorporated (ARAY), the premier radiation oncology company, announced today the appointment of Richard Pettingill, LFACHE as a member of the company's Board of Directors effective May 11, 2012. ...
Devices, Oncology, Personnel
Accuray, CyberKnife, TomoTherapy, radiotherapy

Data from REMEDEE Study Presented at EuroPCR 2012 PARIS, May 17, 2012 (HSMN NewsFeed) -- OrbusNeich today announced that two subgroup analyses from the REMEDEE trial assessing vascular healing of the company's Combo Dual Therapy Stent versus the TAXUS...
Devices, Interventional Cardiology
OrbusNeich, Combo Dual Therapy Stent, drug eluting stent

SAN FRANCISCO, May 17, 2012 (HSMN NewsFeed) -- Varian Medical Systems (VAR) will showcase radiosurgery technologies for treating early-stage inoperable lung cancer and other conditions non-invasively at the 2012 International Conference of the American T...
Devices, Oncology
Varian Medical Systems, RapidArc, Radiosurgery, TrueBeam, radiotherapy

New, longer radiofrequency ablation catheter treats larger areas of disease SUNNYVALE, Calif.--(Healthcare Sales & Marketing Network)--Covidien (NYSE: COV ), a leading global provider of healthcare products, today announced the launch of the HALO90 ULTR...
Devices, Gastroenterology
Covidien, HALO90 ULTRA, Ablation Catheter, Barrett’s esophagus, endoscopy

Acquisition is Next Step in Agilent’s Growing Role in Clinical Diagnostics Dako is one of the leading global providers of cancer diagnostics tools. Acquisition will strategically complement Agilent’s research technologies and will accelerate growth i...
Diagnostics, Personalized Medicine, Mergers & Acquisitions
Agilent Technologies, Dako, cancer diagnostics

Closure Ends Federal Civil and Criminal Investigations of the Company MINNEAPOLIS--(Healthcare Sales & Marketing Network)--Medtronic, Inc. (NYSE: MDT ) today announced it has been notified by the U.S. Department of Justice (DOJ) and the Office of the Un...
Devices, Orthopaedic, Neurosurgery
Medtronic, INFUSE Bone Graft, Bone Graft

AUSTIN, Texas, May 16, 2012 (HSMN NewsFeed) -- Respira Therapeutics, Inc. (http://www.respiratherapeutics.com), developer of a breakthrough, excipient-free, high efficiency, dry powder inhaler (DPI) drug delivery technology for the treatment of respirato...
Devices, Drug Delivery, Personnel
Respira Therapeutics, dry powder inhaler

"APPOSITION III" study results reveal mortality at 1.2% compared to 3.5% in pooled analysis of conventional stents PRINCETON, N.J. & PARIS--(Healthcare Sales & Marketing Network)--STENTYS S.A. (STNT.PA), a medical technology company commercial...
Devices, Interventional Cardiology
STENTYS, Self-Apposing Stent, Acute Myocardial Infarction

World's Smallest Microscope Gets Even Smaller PARIS--(Healthcare Sales & Marketing Network)- Mauna Kea Technologies (MKEA), leader in the endomicroscopy market and developer of Cellvizio®, the world's smallest microscope, announced today that the U...
Devices, Gastroenterology, FDA
Mauna Kea Technologies, Cellvizio, Confocal Laser Endomicroscopy

CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Epizyme, Inc., a company leading the discovery and development of personalized therapeutics for patients with genetically-defined cancers, based on breakthroughs in the field of epigenetics, today a...
Biopharmaceuticals, Personalized Medicine, Personnel
Epizyme, histone methyltransferase

Agreement Expands HYCOR's KOVA Urinalysis Products into 130 Markets Worldwide INDIANAPOLIS, May 16, 2012 (HSMN NewsFeed) -- HYCOR Biomedical, Inc., a leading manufacturer of diagnostic products, and Roche today announced the signing of a global distri...
Diagnostics, Distribution
HYCOR Biomedical, Roche Group, urinalysis

TEWKSBURY, Mass.--(Healthcare Sales & Marketing Network)--Mitralign, Inc., a cardiac device company leading the way in percutaneous mitral valve repair, today announced the closing of a $35 million Series D round of funding. The round was led by Forbion Ca...
Devices, Interventional Cardiology, Venture Capital
Mitralign, annuloplasty, mitral valve, mitral regurgitation

Company Also Announces Appointment of Randall Whitcomb, M.D. as Lead Independent Director MONMOUTH JUNCTION, N.J., May 16, 2012 (HSMN NewsFeed) -- Insmed Incorporated (INSM), a biopharmaceutical company, today announced the appointments of Donald J. H...
Biopharmaceuticals, Personnel
Insmed, inhaled antibiotic, antibiotic

Company sees potential for Thin-Film Nitinol in next-generation flow-diverting stents for treating intracranial aneurysms LOS ANGELES, May 16, 2012 (HSMN NewsFeed) -- NeuroSigma, Inc., a Los Angeles-based medical device company, today announced that i...
Devices, Interventional, Neurology, Acquisitions
NeuroSigma, NSVascular, Nitinol, intracranial aneurysm

Randomized Controlled Trial Results Presented At EuroPCR Demonstrate Advantages Over Uncoated Angioplasty Balloons and Drug-Eluting Stents PARIS--(Healthcare Sales & Marketing Network)-- Adding to the growing body of evidence on a novel interventional c...
Devices, Interventional Cardiology
Medtronic, PACIFIER, IN.PACT, drug eluting balloon, Paclitaxel

BUELACH, SWITZERLAND--(Healthcare Sales & Marketing Network)- Twelve-month results from the BIOSOLVE-I study with the DRug Eluting Absorbable Metal Scaffold (DREAMS) demonstrate safety and confirm vessel vasomotion. The results from the BIOSOLVE-I study we...
Devices, Interventional Cardiology
BIOTRONIK, Drug Eluting Absorbable Metal Scaffold, BIOSOLVE-I

Unparalleled Data Shows Exceptionally Low Late-Lumen Loss, 0% Binary Restenosis and Low Neo-Intimal Volume Obstruction for Ground-Breaking Technology at EuroPCR 2012 Scientific Conference SUNNYVALE, Calif. & PARIS--(Healthcare Sales & Marketing Network)...
Devices, Interventional Cardiology
Elixir Medical, DESolve , Bioresorbable Coronary Scaffold